RE: New Market Maker for Hemo?14 Jul 2021 13:32
Subsequent work through the Company's subsidiary, Immugenyx, LLC ("Immugenyx"), had produced positive preliminary results prior to the emergence of COVID-19. In light of the emergence of the current major pandemic, work has been refocussed on COVID-19 with the aim of producing an effective treatment for those infected with the virus, and Immugenyx is currently taking the necessary steps to take this forward effectively. The work involves transplanting cells from blood samples from patients who have already recovered from COVID-19 into the ApbHC. This process will allow the Company's scientists to recreate a set of anti-SARS-CoV-2 virus antibodies which could be used for the treatment of COVID-19 sufferers.
In view of the continuing international spread of the disease and the propensity for coronaviruses to mutate and produce new strains, the Company's technology, in combination with the use of its humanised mice, should also form the basis for the treatment of future viral outbreaks.
Meanwhile, as announced on 22 April 2020, the Company has progressed its work, currently using blood samples from convalescent patients, to attempt to establish why some individuals who are infected with SARS-CoV-2 are asymptomatic, some exhibit mild symptoms, and some become very sick. This work will be of value in developing new forms of treatment, and especially in managing infection risk and assisting individuals better to establish their real risk of getting sick.
The additional funds raised recently have enabled the Company to take these and other developments forward significantly and at a faster pace.
They need update covid19 treament first. One year after took blood sample and still no resutl yes . What speed it is for research they are? There is no sign at all on how long does it take to trial treatment on next step . Let remember they said in RNS how they want to do with it and now it seem just forget.